Is There a Cure for Lewy Body Dementia?

As of now, there is no cure for Lewy body dementia, and no available treatment can stop or reverse the progression of the disease. That is hard to read, and we understand why. But you deserve an honest answer before anything else.

What we can tell you is that there are treatments that help manage symptoms, that LBD research is getting more attention and funding than it has in the past, and that one drug in particular has shown results that have given the LBD community real reason to pay attention.

What Treatments Are Available Right Now

Every medication currently used for Lewy body dementia was originally developed for a different condition. There are no FDA-approved drugs designed specifically for LBD as yet. The treatments that doctors prescribe are borrowed from Alzheimer’s disease and Parkinson’s disease, and while some of them help, they come with limitations.

Cholinesterase inhibitors are considered the standard treatment for the cognitive symptoms of LBD. These include donepezil, rivastigmine, and galantamine, and in some people they also help reduce hallucinations and other behavioral symptoms. Beyond that, treatment is handled symptom by symptom. Movement problems, sleep disturbances, mood changes, and other symptoms each have their own approaches, and every medication choice in LBD requires extra caution because of the disease’s sensitivity to many common drugs.

The most important thing to understand is that there is no single medication that addresses the full picture of LBD. Managing the disease well usually requires a neurologist with LBD experience, careful coordination between providers, and a family that is informed and willing to advocate.

Why LBD Has Been So Hard to Treat

Lewy body dementia involves abnormal deposits of a protein called alpha-synuclein inside brain cells, and these deposits spread across multiple brain systems over time. That means the symptoms affect cognition, movement, mood, sleep, and basic body functions like blood pressure and digestion, all at once.

Most drugs target a single mechanism or symptom. LBD requires something broader, and until recently, the research infrastructure simply was not there. LBD has historically received far less research funding and attention than Alzheimer’s disease, despite being the second most common form of progressive dementia. But that is changing.

Zervimesine and the SHIMMER Trial

A company called Cognition Therapeutics published the results of a Phase 2 clinical trial called SHIMMER in the journal Alzheimer’s & Dementia. The trial enrolled 130 adults with mild-to-moderate dementia with Lewy bodies and tested an oral drug called zervimesine over six months.

The study confirmed that the drug is safe and well tolerated, which was its primary goal. Beyond that, participants who received zervimesine showed benefits in several symptom areas. Hallucinations and anxiety worsened less than in the placebo group, caregiver distress decreased, and there were positive signals in memory, movement, and daily functioning.

In March 2026, Cognition Therapeutics announced plans to move zervimesine into a late-stage trial for people with DLB psychosis, and in May 2026 it met with the FDA to discuss the design of that study. If successful, zervimesine would become the first FDA-approved treatment developed specifically for dementia with Lewy bodies.

What This Means for Your Family Right Now

Zervimesine is still in clinical development. It has not been approved by the FDA, it is not available as a standard prescription, and larger trials are needed to confirm the results from the Phase 2 study.

That said, for a disease that has had no dedicated treatment pipeline for decades, it is a significant step that a drug is being developed specifically for Lewy body dementia, and it is showing results. That changes the landscape for every family dealing with this disease, even if the direct benefits are still ahead of us.

What You Can Do Now

While research continues, the most important thing you can do is make sure your loved one is receiving the best possible care with what is currently available. That means working with a neurologist or geriatrician who has experience with LBD, ensuring that every provider involved in their care knows about the diagnosis and its medication sensitivities, and staying connected to resources that can help you manage the day-to-day reality of this disease.

We run the only live helpline in the United States dedicated to Lewy body dementia, available every day from 8am to 8pm Eastern time. Whether you have questions about current treatments, need help finding a specialist, or want to talk through what you are seeing at home, we are here. Call us at 516-218-2026 or 833-LBD-LINE, or email norma@lbdrc.org.